On May 20, Infinitus (China) Company Ltd. organized the 3rd “5.20” Infinitus Social Responsibility Day at the company’s production base in Xinhui, a prefecture-level district in Guangdong Province. The theme was “Promoting Chinese Culture of Health Maintenance & Supporting the Healthy China Initiative”.
“5.20 or May 20th is considered Chinese Valentines. In Chinese language, May 20th sounds a bit like “I Love You”, so this date was chosen as the perfect date to hold such an event.
At the event, She Jing, former Vice Minister of Health and former Director of the National Administration of Traditional Chinese Medicine, said, “The 5.20 event demonstrates Infinitus’ confidence in the culture of traditional Chinese medicine (“TCM”) and the company’s ongoing commitment to corporate social responsibilities.”
Huang Jianlong, Managing Director of Infinitus (China), commented, “Industry players can help develop easy-to-understand and modern health concepts based on the culture of TCM, and further bolster public interest and awareness of the Chinese traditions in health.”
Zhou Bangyong, Deputy President of the Council of China Health Care Association, added, “Industry leaders and practitioners should take it as their mission and responsibility to address the increasing expectation for better health and quality of life.”
With years of experience and accumulated expertise in herbal health products, Infinitus continues to organize various events in a move to popularize the science of TCM. The company’s production base in Xinhui has been open to the public since 2005 and was named one of the national educational bases of advocating the culture of TCM. During the period of 2018 to 2020, the Xinhui production base welcomed over 699,500 visitors.
The event also invited the participants take an online tour to the Morinda officinalis plantations of Infinitus in Yunan, Guangdong province. The growers shared information about science-based herbal medicine cultivation. Since 2016, Infinitus has been working with its sister company Tianfangjian (China) Pharmacy Company Ltd., another member of LKK Health Products Group, to establish over 120 plantations for more than 70 Chinese herbal medicine varieties, including M. officinalis, shiitake and Ganoderma lucidum. (Source: PR Newswire)